SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 39.53 |
| Enterprise Value ($M) | 25.92 |
| Book Value ($M) | 11.46 |
| Book Value / Share | 0.26 |
| Price / Book | 3.45 |
| NCAV ($M) | 1.17 |
| NCAV / Share | 0.03 |
| Price / NCAV | 33.70 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.22 |
| Return on Assets (ROA) | -0.69 |
| Return on Equity (ROE) | -1.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.69 |
| Current Ratio | 1.69 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.55 |
| Assets | 33.84 |
| Liabilities | 22.38 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Versant Venture Capital VI, L.P. | 8.40 | 0.00 | |
| 13G/A | Rock Springs Capital Management LP | 0.00 | -100.00 | |
| 13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
| 13G/A | Fmr Llc | 2.24 | -33.33 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 181,326 | 548,669 | 33.05 | |
| 138,118 | 435,407 | 31.72 | |
| 294,730 | 809,520 | 36.41 | |
| 257,098 | 635,997 | 40.42 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TLSA – Tiziana Life Sciences Ltd | TNFA – TNF Pharmaceuticals, Inc. |
| TNXP – Tonix Pharmaceuticals Holding Corp. | TRAW – Traws Pharma, Inc. |
| TTNP – Titan Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io